Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3338-3342

  Thompson, W Joseph ^a,b   Piazza, Gary A ^a   Li, Han ^a   Liu, Li ^a   Fetter, John ^a   Zhu, Bing ^b   Sperl, Gerhard ^a   Ahnen, Dennis ^c   Pamukcu, Rifat ^a  

^a Cell Pathways Inc   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP PHOSPHODIESTERASE; SULINDAC;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON POLYPOSIS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; CADHERINS; COLONIC NEOPLASMS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; HUMANS; ISOENZYMES; KINETICS; PHOSPHODIESTERASE INHIBITORS; PIPERIDINES; PROTEIN KINASES; QUINAZOLINES; SULINDAC; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0034234978     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Piazza, G. A., Rahm, A. L., Krutzsch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., and Pamukcu, R. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55: 3110-3116, 1995.
2. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardiello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis [see comments]. Gastroenterology, 109: 994-998, 1995.
3. Thompson, H. J., Jiang, C., Lu, J., Mehta, R. G., Piazza, G. A., Paranka, N. S., Pamukcu, R., and Ahnen, D. J. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res., 57: 267-271, 1997.
4. Piazza, G. A., Rahm, A. K., Finn, T. S., Fryer, B. H., Li. H., Stoumen, A. L., Pamukcu, R., and Ahnen, D. J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res., 57: 2452-2459, 1997.
5. Lim, J. T., Piazza, G. A., Han, E. K., Delohery, T. M., Li, H., Finn, T. S., Buttyan, R., Yamamoto, H., Sperl, G. J., Brendel, K., Gross, P. H., Pamukcu, R., and Weinstein, I. B. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem. Pharmacol., 58: 1097-1107, 1999.
6. Piazza, G. A., Alberts, D. S., Hixson, L. J., Paranka, N. S., Li, H., Finn, T., Bogert, C., Guillen, J. M., Brendel, K., Gross, P. H., Sperl, G., Ritchie, J., Burt, R. W., Ellsworth, L., Ahnen, D. J., and Pamukcu, R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 57: 2909-2915, 1997.
7. Malkinson, A. M., Koski, K. M., Dwyer-Nield, L. D., Rice, P. L., Rioux, N., Castonguay, A., Ahnen, D. J., Thompson, H., Pamukcu, R., and Piazza, G. A. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis (Lond.), 19: 1353-1356, 1998.
8. Goluboff, E. T., Shabsigh, A., Saidi, J. A., Weinstein, I. B., Mitra, N., Heitjan, D., Piazza, G. A., Pamukcu, R., Buttyan, R., and Olsson, C. A. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. Urology, 53: 440-445, 1999.
9. Drees, M., Zimmermann, R., and Eisenbrand, G. 3′,5′-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res., 53: 3058-3061, 1993.
10. Torphy, T. J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med., 157: 351-370, 1998.
11. Corbin, J. D., and Francis, S. H. Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem., 274: 13729-13732, 1999.
12. Li, L., Yee, C., and Beavo, J. A. CD3-and CD28-dependent induction of PDE7 required for T cell activation. Science (Washington, DC). 283: 848-851, 1999.
13. Prasad, K. N., Becker, G., and Tripathy, K. Differences and similarities between guanosine 3′,5′-cyclic monophosphate phosphodiesterase and adenosine 3′,5′-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture. Proc. Soc. Exp. Biol. Med., 149: 757-762, 1975.
14. Jiang, X., Li, J., Paskind, M., and Epstein, P. M. Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc. Natl. Acad. Sci. USA, 93: 11236-11241, 1996.
15. Kim, D. H., and Lerner, A. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocyte leukemia. Blood, 92: 2484-2494, 1998.
16. Whalin, M. E., Strada, S. J., and Thompson, W. J. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain. Biochim. Biophys. Acta, 972: 79-94, 1988.
17. Stoner, G. D., Budd, G. T., Ganapathi, R., De Young, B., Kresty, L. A., Nitert, M., Fryer, B., Church, J. M., Provencher, K., Pamukcu, R., Piazza, G., Hawk, E., Kelloff, G., Elson, P., and van Stolk, R. U. Sulindac Sulfone Induced Regression of Rectal Polyps in Patients with Familial Adenomatous Polyposis. Colon Cancer Prevention: Dietary Modulation of Cellular and Molecular Mechanisms, pp. 45-53, New York: Kluwer Academic/Plenum Publishing Corp., 1999.
18. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1: 229-233, 1992.
19. Stewart, D. B., and Nelson, W. J. Identification of four distinct pools of catenins in mammalian cells and transformation-dependent changes in catenin distributions among these pools. J. Biol. Chem., 272: 29652-29662, 1997.
20. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kanzler, K. W. Identification of c-MYC as a target of the APC pathway [see comments]. Science (Washington DC), 281: 1509-1512, 1998.
21. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J., 17: 1371-1384, 1998.
22. Seeling, J. M., Miller, J. R., Gil, R., Moon, R. T., White, R., and Virshup, D. M. Regulation of β-catenin signaling by the B56 subunit of protein phosphatase 2A. Science (Washington DC), 283: 2089-2091, 1999.
23. Yamamoto, H., Kishida, S., Kishida, M., Ikeda, S., Takada, S., and Kikuchi, A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3β regulates its stability. J. Biol. Chem., 274: 10681-10684, 1999.
24. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC [see comments]. Science (Washington DC), 275: 1787-1790, 1997.
25. Easwaran, V., Song, V., Polakis, P., and Byers, S. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of β-catenin-lymphocyte enhancer-binding factor signaling. J. Biol. Chem., 274: 16641-16645, 1999.
26. Morin, P. J., Vogelstein, B., and Kinzler, K. W. Apoptosis and APC in colorectal tumorigenesis. Proc. Nati. Acad. Sci. USA, 93: 7950-7954, 1996.
27. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA, 92: 3046-3050, 1995.
28. Mulsch, A., Bauersachs, J., Schafer, A., Stasch, J. P., Kast, R., and Busse, R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol., 120: 681-689, 1997.
29. Wu, C. F., Bishopric, N. H., and Pratt, R. E. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem., 272: 14860-14866, 1997.
30. Loweth, A. C., Williams, G. T., Scarpello, J. H., and Morgan, N. G. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett., 400: 285-288, 1997.
31. Suenobu, N., Shichiri, M., Iwashina, M., Marumo, F., and Hirata, Y. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Arterioscler. Thromb. Vasc. Biol., 19: 140-146, 1999.
32. Chiche, J. D., Schlutsroeyer, S. M., Bloch, D. B., de la Monte, S. M., Roberts, J. D., Jr., Filippov, G., Janssens, S. P., Rosenzweig, A., and Bloch, K. D. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem., 273: 34263-34271, 1998.
33. Suhasini, M., Li, H., Lohmann, S. M., Boss, G. R., and Pilz, R. B. Cyclic-GMP-dependent protein kinase inhibits the Ras/mitogen-activated protein kinase pathway. Mol. Cell. Biol., 18: 6983-6994, 1998.
34. Yamamoto, Y., Yin, M. J., Lin, K. M., and Gaynor, R. B. Sulindac inhibits activation of the NF-κB pathway. J. Biol. Chem., 274: 27307-27314, 1999.
35. Shlutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., and Ben Ze'ev, A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, 96: 5522-5527, 1999.
36. Tetsu, O., and McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
37. He, T. C., Chan, T. A., Vogelstein, B., and Kinzler, K. W. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell, 99: 335-345, 1999.
38. Thompson, W. J., Terasaki, W. L., Epstein, P. M., and Strada, S. J. Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv. Cyclic Nucleotide Res., 10: 69-92, 1979.
39. Reynolds, P. D., Strada, S. J., and Thompson, W. J. Cyclic GMP accumulation in pulmonary microvascular endothelial cells measured by intact cell prelabeling. Life Sci., 60: 909-918, 1997.